UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nomogram model of serum thymidine kinase 1 combined with ultrasonography for prediction of central lymph node metastasis risk in patients with papillary thyroid carcinoma pre-surgery

Frontiers in endocrinology (Lausanne), 2024-06, Vol.15, p.1366219

2024

Volltextzugriff (PDF)

Concentration of human thymidine kinase 1 discover invisible malignant human tumours

European journal of cell biology, 2022-09, Vol.101 (4), p.151280-151280, Article 151280

2022

Volltextzugriff (PDF)

Novel neutralizing chicken IgY antibodies targeting 17 potent conserved peptides identified by SARS-CoV-2 proteome microarray, and future prospects

Frontiers in immunology, 2022-12, Vol.13, p.1074077-1074077

2022

Volltextzugriff (PDF)

Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery

Journal of Immunology Research, 2023-03, Vol.2023, p.7612566-14

2023

Volltextzugriff (PDF)

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?

Discover. Oncology, 2023-02, Vol.14 (1), p.21-21, Article 21

2023

Volltextzugriff (PDF)

Hadrontherapy Interactions in Molecular and Cellular Biology

International journal of molecular sciences, 2020-01, Vol.21 (1), p.133

2020

Volltextzugriff (PDF)

A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index

Scientific reports, 2016-08, Vol.6 (1), p.31132-31132, Article 31132

2016

Volltextzugriff (PDF)

Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people

Cancer biomarkers : section A of Disease markers, 2016-04, Vol.16 (4), p.529-536

2016

Volltextzugriff (PDF)

Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis

Future science OA, 2021-08, Vol.7 (7), p.FSO717-FSO717

2021

Volltextzugriff (PDF)

Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker

Tumor biology, 2017-06, Vol.39 (6), p.1010428317706479-1010428317706479

2017

Volltextzugriff (PDF)

Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay

Sensors (Basel, Switzerland), 2011-12, Vol.11 (12), p.11064-11080

2011

Volltextzugriff (PDF)

STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data

Future science OA, 2021-03, Vol.7 (3), p.FSO661-FSO661

2021

Volltextzugriff (PDF)

Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

International journal of clinical oncology, 2010-08, Vol.15 (4), p.359-368

2010

Volltextzugriff (PDF)

Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients

Journal of cancer research and clinical oncology, 2010-08, Vol.136 (8), p.1193-1199

2010

Volltextzugriff (PDF)

Thymidine Kinase 1 in Serum Predicts Increased Risk of Distant or Loco-regional Recurrence Following Surgery in Patients with Early Breast Cancer

Anticancer research, 2006-11, Vol.26 (6C), p.4753-4759

2006

Volltextzugriff (PDF)

Serological Thymidine Kinase 1 (STK1) Indicates an Elevated Risk for the Development of Malignant Tumours

Anticancer research, 2008-11, Vol.28 (6B), p.3897-3907

2008

Volltextzugriff (PDF)

A Novel Model Using Serum Thymidine Kinase 1 and Low-dose Computed Tomography Parameters to Predict Three-year Lung Cancer Risk in People with Pulmonary Nodules: A Retrospective Study

Journal of Cancer, 2024, Vol.15 (3), p.737-746

2024

Volltextzugriff (PDF)

Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

European journal of cell biology, 2009-12, Vol.88 (12), p.779-785

2009

Volltextzugriff (PDF)

The proliferation marker thymidine kinase 1 in clinical use

Molecular and clinical oncology, 2013-01, Vol.1 (1), p.18-28

2013

Volltextzugriff (PDF)

Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual

Viral immunology, 2023-04, Vol.36 (3), p.153

2023

Volltextzugriff (PDF)

A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment

Molecular and clinical oncology, 2020-05, Vol.12 (5), p.440-450

2020

Volltextzugriff (PDF)

Serum 8-Oxo-dG as a Predictor of Sensitivity and Outcome of Radiotherapy and Chemotherapy of Upper Gastrointestinal Tumours

Oxidative medicine and cellular longevity, 2018-01, Vol.2018 (2018), p.1-8

2018

Volltextzugriff (PDF)

The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis

Genetic testing and molecular biomarkers, 2017-08, Vol.21 (8), p.471-478

2017

Volltextzugriff (PDF)

Serological TK1 predict pre-cancer in routine health screenings of 56,178 people

Cancer biomarkers : section A of Disease markers, 2018-01, Vol.22 (2), p.237-247

2018

Volltextzugriff (PDF)

Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix

BMC cancer, 2013-05, Vol.13 (1), p.249-249, Article 249

2013

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(99)

Sprache

Englisch
(98)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nomogram model of serum thymidine kinase 1 combined with ultrasonography for prediction of central lymph node metastasis risk in patients with papillary thyroid carcinoma pre-surgery

Concentration of human thymidine kinase 1 discover invisible malignant human tumours

Novel neutralizing chicken IgY antibodies targeting 17 potent conserved peptides identified by SARS-CoV-2 proteome microarray, and future prospects

Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?

Hadrontherapy Interactions in Molecular and Cellular Biology

A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index

Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people

Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis

Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker

Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay

STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data

Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients

Thymidine Kinase 1 in Serum Predicts Increased Risk of Distant or Loco-regional Recurrence Following Surgery in Patients with Early Breast Cancer

Serological Thymidine Kinase 1 (STK1) Indicates an Elevated Risk for the Development of Malignant Tumours

A Novel Model Using Serum Thymidine Kinase 1 and Low-dose Computed Tomography Parameters to Predict Three-year Lung Cancer Risk in People with Pulmonary Nodules: A Retrospective Study

Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

The proliferation marker thymidine kinase 1 in clinical use

Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual

A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment

Serum 8-Oxo-dG as a Predictor of Sensitivity and Outcome of Radiotherapy and Chemotherapy of Upper Gastrointestinal Tumours

The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis

Serological TK1 predict pre-cancer in routine health screenings of 56,178 people

Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix

Suchergebnisse filtern